Have a website account?
for exclusive website content.
to TCR Journal
Submit Multimedia Files
Peer Review Process
Conflict of Interest
Human and Animal Rights
Publish Ahead of Print
Vol 1, No 1 (June 2012)
Vol 1, No 1 (June 2012): Translational Cancer Research
Translational Cancer Research - Message from the Editor-in-Chief
Eric Y Chuang, Sc.D.
DNA-PK targeting virotherapy, a promising approach
Inhibitors of DNA repair for cancer therapy, ready for prime time?
Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA
Takashi Kon, Xiuwu Zhang, Qian Huang, Zhonghui Yang, Shanling Liu, Bin Yan, Fang Li, He Wang, Chuan-Yuan Li
Anti-HER2 therapies: when more is more
Monica Arnedos, Britta Weigelt, Jorge S. Reis-Filho
is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis
Seong-Hoon Park, Yuming Zhu, Ozkan Ozden, Hyun-Seok Kim, Haiyan Jiang, Chu-Xia Deng, David Gius, Athanassios Vassilopoulos
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment
Feng-Ming Hsu, Shichuan Zhang, Benjamin P.C. Chen
Normal tissue protection for improving radiotherapy: where are the Gaps?
Pataje G.S. Prasanna, Helen B. Stone, Rosemary S. Wong, Jacek Capala, Eric J. Bernhard, Bhadrasain Vikram, C. N. Coleman
Bevacizumab: where do we go from here in breast cancer?
Faina Nakhlis, Mehra Golshan
Neoadjuvant bevacizumab and chemotherapy in breast cancer
Suparna B. Wedam, Sherry X. Yang